News
5d
Pharmaceutical Technology on MSNAscletis’s daily acne tablet set for China review after Phase III winThe Phase III trial, conducted by Chinese license partner Ascletis, produced strong results for denifanstat compared to ...
Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results